It is known that certain phthalates that resemble estradiol, a treatment for menopausal symptoms, may induce breast cancer; for example, DBP exposure was associated with an approximately two-fold increase in the rate of ER+ BC [184]. This evidence concerns the gene ESR1 and breast cancer.